342 related articles for article (PubMed ID: 18830039)
1. [Evidence and utility of etidronate for the treatment of osteoporosis].
Takada J; Iba K; Yamashita T; Yoshizaki T
Clin Calcium; 2008 Oct; 18(10):1427-33. PubMed ID: 18830039
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and tolerability of once-weekly administration of 35 mg alendronate and 17.5 mg risedronate].
Kishimoto H
Nihon Rinsho; 2007 Nov; 65 Suppl 9():365-8. PubMed ID: 18161133
[No Abstract] [Full Text] [Related]
3. [Evidence of risedronate for treatment of osteoporosis].
Soen S
Nihon Rinsho; 2007 Nov; 65 Suppl 9():344-7. PubMed ID: 18161128
[No Abstract] [Full Text] [Related]
4. [Evidence for efficacy of active vitamin D3 as an anti-osteoporotic drug].
Inoue D
Clin Calcium; 2008 Oct; 18(10):1469-75. PubMed ID: 18830044
[TBL] [Abstract][Full Text] [Related]
5. Effect of intermittent cyclical etidronate therapy on corticosteroid induced osteoporosis in Japanese patients with connective tissue disease: 3 year followup.
Sato S; Ohosone Y; Suwa A; Yasuoka H; Nojima T; Fujii T; Kuwana M; Nakamura K; Mimori T; Hirakata M
J Rheumatol; 2003 Dec; 30(12):2673-9. PubMed ID: 14719212
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of primary osteoporosis in men].
Yamaguchi T; Sugimoto T
Clin Calcium; 2006 Mar; 16(3):474-9. PubMed ID: 16508131
[TBL] [Abstract][Full Text] [Related]
7. Longterm effect of intermittent cyclical etidronate therapy on corticosteroid-induced osteoporosis in Japanese patients with connective tissue disease: 7-year followup.
Sato S; Takada T; Katsuki Y; Kimura N; Kaneko Y; Suwa A; Hirakata M; Kuwana M
J Rheumatol; 2008 Jan; 35(1):142-6. PubMed ID: 18050368
[TBL] [Abstract][Full Text] [Related]
8. [Alendronate for treatment of osteoporoses].
Harada A
Nihon Rinsho; 2009 May; 67(5):943-7. PubMed ID: 19432114
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy and tolerability of risedronate for the treatment of osteoporosis].
Kishimoto H
Clin Calcium; 2008 Oct; 18(10):1417-26. PubMed ID: 18830038
[TBL] [Abstract][Full Text] [Related]
10. [New development in bisphosphonate treatment. Bisphosphonates for the treatment of glucocorticoid-induced osteoporosis].
Soen S
Clin Calcium; 2009 Jan; 19(1):44-53. PubMed ID: 19122264
[TBL] [Abstract][Full Text] [Related]
11. [FACT study].
Tanaka I; Oshima H
Nihon Rinsho; 2007 Nov; 65 Suppl 9():280-5. PubMed ID: 18161120
[No Abstract] [Full Text] [Related]
12. [Bisphosphontes].
Ichimura S
Clin Calcium; 2005 Apr; 15(4):583-90. PubMed ID: 15802769
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
Cruse LM; Valeriano J; Vasey FB; Carter JD
J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
[TBL] [Abstract][Full Text] [Related]
14. Osteoporosis prevention and treatment.
Sambrook PN; Eisman JA
Med J Aust; 2000 Mar; 172(5):226-9. PubMed ID: 10776395
[TBL] [Abstract][Full Text] [Related]
15. [Concurrent treatment of osteoporosis including vitamin K].
Kobayashi S; Shiraki M; Takaoka K
Clin Calcium; 2007 Nov; 17(11):1731-7. PubMed ID: 17982194
[TBL] [Abstract][Full Text] [Related]
16. [Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women--update 2009].
Dimai HP; Pietschmann P; Resch H; Preisinger E; Fahrleitner-Pammer A; Dobnig H; Klaushofer K;
Wien Med Wochenschr Suppl; 2009; (122):1-34. PubMed ID: 19484202
[TBL] [Abstract][Full Text] [Related]
17. [New bone density conservation agents for osteoporosis under research and development: PTH (1-34)].
Endo I; Matsumoto T
Nihon Rinsho; 2007 Nov; 65 Suppl 9():443-6. PubMed ID: 18161146
[No Abstract] [Full Text] [Related]
18. [Progress in the treatment of osteoporosis].
Sugimoto T
Rinsho Byori; 2008 Oct; 56(10):887-93. PubMed ID: 19068785
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis.
Amiche MA; Albaum JM; Tadrous M; Pechlivanoglou P; Lévesque LE; Adachi JD; Cadarette SM
Osteoporos Int; 2016 Jun; 27(6):1989-98. PubMed ID: 26782683
[TBL] [Abstract][Full Text] [Related]
20. [Measures for osteoporosis in the dermatological field--vitamin D3 and bisphosphonate].
Okada N
Clin Calcium; 2004 Oct; 14(10):145-9. PubMed ID: 15577149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
